Bedside management of the gasping, tachypneic patient: work-of-breathing assessment, accessory muscle use, P-SILI prevention, and timely intubation vs noninvasive support.
Acute severe respiratory distress is characterized by severe tachypnea (respiratory rate > 30–35 bpm), vigorous accessory muscle recruitment, sternocleidomastoid retractions, nasal flaring, and abdominal paradox. It indicates that the patient's ventilatory demand exceeds their neuromuscular capacity. Bedside triage requires identifying impending respiratory arrest, distinguishing upper from lower airway emergencies, and preventing Patient Self-Inflicted Lung Injury (P-SILI).
Caution
Dangerous Diagnosis Not to Miss: Acute upper airway obstruction (laryngeal edema, expanding neck hematoma, foreign body), acute severe asthma with silent chest, impending respiratory arrest from muscle exhaustion, and SCAPE flash pulmonary edema.
Work of Breathing Signs: Sternocleidomastoid and intercostal retractions, tracheal tug, diaphoresis, inability to speak in full sentences (1–2 word dyspnea), and thoracoabdominal paradox (inward movement of abdominal wall during inspiration indicating diaphragmatic exhaustion).
Vital Signs: Severe tachypnea (> 35 bpm) or ominous bradypnea (< 10 bpm), tachycardia, hypertension or impending hypotension.
Upper Airway Stridor: Inspiratory stridor indicates critical extrathoracic airway narrowing (edema, hematoma, tumor); mandates immediate expert airway preparation.
Silent Chest: In severe asthma, absence of wheezing accompanied by exhaustion and lethargy indicates zero air movement and imminent cardiopulmonary arrest.
Progressive Encephalopathy: Agitation progressing to somnolence indicates critical hypercapnia or severe cerebral hypoxia.
Positioning: Sit the patient fully upright (optimizes diaphragm excursion and FRC).
High-Flow Nasal Cannula (HFNC): Initiate at 50–60 L/min and 100% FiO2 to reduce work of breathing, wash out dead space, and generate dynamic PEEP.
Noninvasive Ventilation (NIV / BiPAP): If acute cardiogenic pulmonary edema (CPAP 8–12 cmH2O) or acute COPD exacerbation (IPAP 12–16, EPAP 4–6 cmH2O) is present.
Urgent Bronchodilator / Vasodilator Therapy: Continuous nebulized albuterol for bronchospasm; high-dose IV nitrates for SCAPE.
Caution
Common Diagnostic Trap: Being falsely reassured by a 'normal' pulse oximetry reading (SpO2 96%) in a patient with severe tachypnea and accessory muscle use. High work of breathing consumes immense metabolic energy; when respiratory muscles fatigue, sudden catastrophic respiratory arrest occurs.
Hypoxemic Respiratory Failure: Escalation ladders, P-SILI physiology, and ROX index.
Hypercapnic Respiratory Failure: Ventilatory pump failure and NIV protocols.
Difficult Airway: Pre-oxygenation, induction agents, and rescue surgical airway algorithms.
Cardiogenic Pulmonary Edema: Nitrates, CPAP, and DOSE diuresis.
Asthma & COPD Exacerbation: Dynamic hyperinflation and bronchodilator strategies.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.
From post-intubation verification and lung-protective settings to mechanics optimization.
From readiness screening and spontaneous breathing trials to extubation and post-extubation support.
From eligibility screening and team preparation to 16-hour proning cycles and response evaluation.
From initial noninvasive modality selection to ROX index tracking and timely intubation triggers.
Pathophysiologic mechanisms (shunt vs V/Q mismatch), dynamic ROX index trajectories, P-SILI prevention, and evidence-based oxygen escalation ladders.
Mechanism-based diagnosis of acute and acute-on-chronic hypercapnia, controlled oxygen, NIV, invasive ventilation, auto-PEEP troubleshooting, neuromuscular monitoring, and post-acute planning.
Core taxonomy (Types I–IV), alveolar gas exchange physiology, work-of-breathing mechanics, and escalation thresholds in acute respiratory failure.
Acute, diffuse inflammatory lung injury causing hypoxemia and bilateral infiltrates not fully explained by cardiac failure or fluid overload.
Pathophysiology of dynamic hyperinflation, auto-PEEP hemodynamics, stepped acute pharmacotherapy, and ventilator mechanics in status asthmaticus.
Pathophysiology of acute-on-chronic hypercapnia, controlled oxygen targets (88–92%), evidence-based NIV, and auto-PEEP matching mechanics.
The 7 Ps of ICU intubation, the physiologically difficult airway, BOUGIE/DEVICE video laryngoscopy trials, hemodynamic optimization, waveform capnography, and scalpel-bougie cricothyroidotomy.
Hydrostatic pulmonary edema physiology, SCAPE vs decompensated HF vs cardiogenic shock, NIV, titrated vasodilators when hypertensive, diuresis, and sequential nephron blockade.
Phased energy and protein delivery, early enteral nutrition when safe, indirect calorimetry, refeeding prevention, feeding-intolerance troubleshooting, and individualized parenteral nutrition timing.